Increasing Doxycycline Hyclate Photostability by Complexation with β-Cyclodextrin

被引:0
作者
Ana Carolina Kogawa
Ariana Zoppi
Mario Alfredo Quevedo
Hérida Regina Nunes Salgado
Marcela Raquel Longhi
机构
[1] Faculdade de Ciências Farmacêuticas UNESP,Departamento de Fármacos e Medicamentos
[2] CONICET-Universidad Nacional de Córdoba,Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA)
[3] Universidad Nacional de Córdoba,Departamento de Farmacia, Facultad de Ciencias Químicas
来源
AAPS PharmSciTech | 2014年 / 15卷
关键词
β-cyclodextrin; doxycycline hyclate; microbiological assay; molecular modeling; photostability;
D O I
暂无
中图分类号
学科分类号
摘要
Doxycycline hyclate (DOX) is a highly photosensitive drug, a feature that limits the stability of the corresponding dosage forms. The main objectives of this work were the preparation and characterization of an inclusion complex of DOX with β-cyclodextrin (βCD) and to investigate if this approach could improve the photostability of the drug. Guest-host interactions were investigated using nuclear magnetic resonance, which were afterwards combined with molecular modeling methods to study the complex formation and its three-dimensional structure was proposed. A freeze-drying method was applied to obtain the complex in the solid state, which was further confirmed by thermal and spectroscopic techniques. To evaluate the complexation effect on DOX integrity, the photostability of the inclusion complex was studied, with a significant decrease in the photodegradation of DOX being found in aqueous solution upon complexation. Finally, the photoprotection produced by the complexation was evaluated by means of an antimicrobial assay. Overall, the presented results suggest that the formulation of DOX complexed with βCD constitutes an interesting approach for the preparation of pharmaceutical dosage forms of DOX with enhanced stability properties.
引用
收藏
页码:1209 / 1217
页数:8
相关论文
共 97 条
  • [1] Kogawa AC(2012)Doxycycline hyclate: a review of properties, applications and analytical methods Int J Life Sci Pharma Res 2 11-25
  • [2] Salgado HRN(2007)Cyclodextrins as pharmaceutical solubilizers Adv Drug Deliv Rev 59 645-666
  • [3] Brewster ME(2010)Pharmaceutical applications of cyclodextrins: basic science and product development J Pharm Pharmacol 62 1607-1621
  • [4] Loftsson T(2012)Cyclodextrins as functional excipients: methods to enhance complexation efficiency J Pharm Sci 101 3019-3032
  • [5] Loftsson T(2012)Interaction of sulfadiazine with cyclodextrins in aqueous solution and solid state Carbohydr Polym 87 1980-1988
  • [6] Brewster ME(2011)Enalapril: β-CD complex: stability enhancement in solid state Carbohydr Polym 86 716-721
  • [7] Loftsson T(2013)Binding of sulfamethazine to β-cyclodextrin and methyl-β-cyclodextrin AAPS PharmSciTech 14 727-735
  • [8] Brewster ME(2005)Cyclodextrins in drug delivery Expert Opin Drug Deliv 2 335-351
  • [9] Delrivo A(2001)Formulation and stability testing of photolabile drugs Int J Pharm 225 1-14
  • [10] Zoppi A(2013)Characterization of the hydrochlorothiazide: β-cyclodextrin inclusion complex. Experimental and theoretical methods J Phys Chem B 117 206-217